The Discounted Cash Flow (DCF) valuation of Maxigen Biotech Inc (1783.TW) is 59.01 TWD. With the latest stock price at 41.95 TWD, the upside of Maxigen Biotech Inc based on DCF is 40.7%.
Based on the latest price of 41.95 TWD and our DCF valuation, Maxigen Biotech Inc (1783.TW) is a buy. buying 1783.TW stocks now will result in a potential gain of 40.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.0% | 6.3% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 42.15 - 114.66 | 59.01 |
| Upside | 0.5% - 173.3% | 40.7% |